| Literature DB >> 33981139 |
Martina Votto1,2, Maria De Filippo1,2, Amelia Licari1,2, Alessia Marseglia2, Mara De Amici3, Gian Luigi Marseglia1,2.
Abstract
Severe uncontrolled asthma is a complex and heterogeneous disease. A multidisciplinary assessment is required to correctly identify and manage children and adolescents with severe asthma because they may require strict monitoring and additional treatment with advanced targeted therapies. Recent research efforts have focused on identifying epidemiologic, clinical, and molecular mechanisms that underlie severe asthma, leading to the recognition of different phenotypes and endotypes and identifying biomarkers able to predict the response to biologic therapies. Additional progress has occurred by introducing biological therapies that have revolutionized the care of chronic allergic diseases in the adult and pediatric population. In this review, we briefly summarized the current literature on biological therapies to treat severe asthma in children and adolescents.Entities:
Keywords: adolescents; biological therapy; children; endotype; phenotype; severe asthma
Year: 2021 PMID: 33981139 PMCID: PMC8107006 DOI: 10.2147/BTT.S252574
Source DB: PubMed Journal: Biologics ISSN: 1177-5475